Search results
Oct 18, 2012 · Charles Frederick Stanley YARNOLD. Filter appointments Filter appointments Current appointments Total number of appointments 2 Date of birth June 1973. ARCHENFIELD ...
“These results support the current NICE [National Institute for Health and Clinical Excellence] guidelines for 40 Gy in 15 fractions as the UK standard of care for all patients with invasive breast cancer,” stated J. R. Yarnold, MD, lead author, on behalf of the START investigators.
May 16, 2024 · Yarnold, Charles, (fl 1809-1821), surgeon, historian. This page summarises records created by this Person. The summary includes a brief description of the collection (s) (usually...
Oct 12, 2023 · In making the decision, the authority has referred to the Housing Act 2004, associated regulations and Herefordshire Council’s published HMO amenity guide and enforcement policy. Contact: Charles...
- Shorter Treatment Courses
- Start Trials
- Fast Trial
- Fast-Forward
- Making A Difference
- Looking Back
The way in which fractions, or daily doses, of curative radiotherapy are divided has changed in recent years. The total dose of curative radiotherapy given to patients is conventionally divided into many small fractions spread over several weeks. For decades fraction sizes, measured in gray (Gy), remained small (typically 2Gy) for all patients, all...
Historically, women received radiotherapy in 25 daily doses of 2Gy over five weeks after their breast surgery. The first practice-changing trials led by Professor Yarnold were the START-A and START-B trials, carried out between 1998 and 2002. The START-A trial was based on results of the START-P pilot trial, which he led in the 1980’s. This was the...
The next step was the FAST trial, which tested the safety of increasing the fraction size from around 3Gy to 6Gy and reducing reduce the number of fractions from 25 to five. The FAST trial compared late side effects – those appearing months or years after treatment – after hypofractionated radiotherapy with those that appeared after conventional ra...
The START and FAST trials laid the groundwork for the recent FAST-Forward trial, testing an even shorter treatment course of five fractions of breast radiotherapy delivered in a single week. This was recently found to be safe and effective, when compared to the three-week standard established by the START trial, and has become a UK standard for pat...
Thanks to large, well-conducted clinical trials like START, FAST and FAST-Forward, coordinated by the ICR-CTSU, radiotherapy research continues to improve outcomes for many women out there. Hypofractionation provides a clear example of how a better understanding of biology, coupled with technological advances, can offer benefit for both patients wi...
After being involved in so many practice-changing radiotherapy trials that have transformed treatment for countless patients, it is difficult to quantify Professor Yarnold’s impact on the field of cancer research. Not only was he involved in breast cancer trials, he also led many other trials, including the first-ever randomised trial at the ICR an...
Apr 6, 2018 · His clinical practice and research interests have concentrated on the role of radiotherapy in breast cancer and he has led 17 randomised clinical trials testing advances in treatment for cancer patients.
$1,500. Donate. United Airlines NYC Half with Team Fox. Story. Updates 0. I am running the United Airlines NYC Half with Team Fox! Thank you for visiting my fundraising page! I’m lacing up with Team Fox at the United Airlines NYC Half to raise critical funds for Parkinson’s disease (PD) research.
